NEW YORK (GenomeWeb News) – Evotec today announced a collaboration to support the development of compounds in development at Dow AgroSciences.
As part of the deal, Evotec will provide its quantitative chemical proteomics services to "de-convolute phenotypic screening results" obtained by Dow AgroSciences, a wholly owned subsidiary of Dow Chemical.
Financial and other terms were not disclosed.
"This collaboration highlights the broad applicability of Evotec's industry leading chemical proteomics platform to determine cellular target affinities and mechanisms of action on a proteome wide level and in a native context," Mario Polywka, COO of Evotec, said in a statement.